Miller Wealth Advisors’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.8K Hold
2,820
– – 0.01% 59
2026
Q2
$15.3K Buy
+2,820
New +$11.8K 0.01% 66

Other funds holding STLN

Miller Wealth Advisors's STLN Position: Q3 2026 in Review

Miller Wealth Advisors held its Starling Oncology (STLN) position steady in Q3 2026 at 2,820 shares worth $17.8K. The position accounts for 0.01% of the portfolio, ranked #59.

Miller Wealth Advisors first reported a position in STLN in Q2 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Miller Wealth Advisors held 2,820 shares of Starling Oncology worth $17.8K as of Q3 2026.
  • Miller Wealth Advisors left its Starling Oncology share count unchanged in Q3 2026.
  • Starling Oncology made up 0.01% of Miller Wealth Advisors's portfolio in Q3 2026, its #59 holding.
  • Miller Wealth Advisors first reported a position in Starling Oncology in Q2 2026 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Miller Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.